Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway.
Saved in:
| Title: | Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway. |
|---|---|
| Authors: | Zeng H; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Zeng X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Wang C; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China.; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Wang G; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Tian Q; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Zhao J; Department of Clinical Laboratory, Core Unit of National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450046, China., Zhao L; Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China., Li R; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Luo Y; Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Province, Zhengzhou, 450046, China., Peng H; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China., Zhang Z; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. ZQzhang111@outlook.com., Li X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. drlxf2080@163.com., Wu X; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, 450046, China. wuxx-415@126.com. |
| Source: | Drug delivery and translational research [Drug Deliv Transl Res] 2025 Mar; Vol. 15 (3), pp. 992-1010. Date of Electronic Publication: 2024 Jun 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2190-3948 |
|---|---|
| DOI: | 10.1007/s13346-024-01653-3 |
